Division of Artificial Intelligence in Medicine, Departments of Medicine, Imaging and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Suite Metro 203, Los Angeles, CA, 90048, USA.
Department of Cardiac Sciences, University of Calgary and Libin Cardiovascular Institute, Calgary, AB, Canada.
J Nucl Cardiol. 2022 Aug;29(4):1754-1762. doi: 10.1007/s12350-022-02977-8. Epub 2022 May 4.
Artificial intelligence (AI) techniques have emerged as a highly efficient approach to accurately and rapidly interpret diagnostic imaging and may play a vital role in nuclear cardiology. In nuclear cardiology, there are many clinical, stress, and imaging variables potentially available, which need to be optimally integrated to predict the presence of obstructive coronary artery disease (CAD) or predict the risk of cardiovascular events. In spite of clinical awareness of a large number of potential variables, it is difficult for physicians to integrate multiple features consistently and objectively. Machine learning (ML) is particularly well suited to integrating this vast array of information to provide patient-specific predictions. Deep learning (DL), a branch of ML characterized by a multi-layered convolutional model architecture, can extract information directly from images and identify latent image features associated with a specific prediction. This review will discuss the latest AI applications to disease diagnosis and risk prediction in nuclear cardiology with a focus on potential clinical applications.
人工智能(AI)技术已成为一种高效的方法,可以准确快速地解读诊断成像,并可能在核心脏病学中发挥重要作用。在核心脏病学中,有许多临床、应激和成像变量可能存在,需要进行最佳整合以预测阻塞性冠状动脉疾病(CAD)的存在或预测心血管事件的风险。尽管临床意识到有大量潜在的变量,但医生很难始终如一地客观地整合多种特征。机器学习(ML)特别适合整合这大量信息,以提供针对患者的预测。深度学习(DL)是 ML 的一个分支,其特点是具有多层卷积模型架构,可以直接从图像中提取信息,并识别与特定预测相关的潜在图像特征。本文将讨论 AI 在核心脏病学中的疾病诊断和风险预测中的最新应用,重点介绍潜在的临床应用。